drugset / Trial / NCT00464438

A Study to Evaluate the Safety and Efficacy of Gatifloxacin for the Treatment of Bacterial Conjunctivitis

NCT00464438

Phase 4 Completed 171 enrolled Allergan
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This is a 7 day study to evaluate the safety and efficacy of topical gatifloxacin ophthalmic solution for the treatment of bacterial conjunctivitis in subjects from birth to 31 days of age

Timeline

Start
2007-06
Primary completion
2008-09
Completion
2008-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Gatifloxacin Small molecule Topical
Comparator Moxifloxacin Small molecule 0.5 % Topical